AngioDynamics Inc at Barclays Global Healthcare Conference Transcript
Good morning, everybody. My name is Luke Sergott. I cover life science tools and diagnostics here at Barclays, and this is my foray into the biotech space -- or I'm sorry, med device space. I have Stephen Trowbridge with me and Jim Clemmer of AngioDynamics who are going to give a presentation.
Good morning, Luke. Thank you Thanks Barclays for having the courage to plan an in-person meeting. This is a challenging environment. So thanks for the invitation. Let me remind you, sophisticated investors, you understand what you hear this morning, our ideas, projections, plans, strategies. And I always consider the forward-looking statements that you're here to make sure you make good decisions as you invest. .
So let's talk about AngioDynamics for a little bit. We're a company in transformation. And what we're doing is transforming from -- we've always been a diversified medical device company. Well, today, we're
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
